Affymetrix Appoints Masao Yoneyama as General Manager of Japan Operations
Affymetrix Inc. announced that it has named Masao Yoneyama, Ph.D., General Manager of Japan Operations. As part of this role, Dr. Yoneyama has been elected as Affymetrix' representative director for Japan and will be responsible for growing the business across the country.
Dr. Yoneyama brings 20 years of experience in the life sciences industry to Affymetrix. His specific areas of expertise are toxicogenomics, pharmacogenomics and molecular diagnostics. He joins Affymetrix from Daiichi Pure Chemicals Co., Ltd., where he was the general manager of business development. He was responsible for research and development and creating new business opportunities in several different areas, including personalized medicine, point-of-care testing, food safety and toxicology.
Dr. Yoneyama holds a bachelor's degree in chemistry, Master of Science degree and a doctorate in toxicology from Utah State University. He also holds a diploma from Ikutoku Technical College (Japan) in chemical engineering.
Most read news
Topics
Organizations
Other news from the department people
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Ocean Optics Names Winner of 2010 Young Investigator Award
Can you analyze me now? Cell phones bring spectroscopy to the classroom
Roche acquires innovatis AG to complement its product portfolio in the rapidly growing area of cellular analytics
Urine samples could be used to predict responses to drugs, say researchers
Abbott enters into agreement with Inpeco to expand laboratory automation capabilites
Phosphorylated Akt isoforms revealed as novel cancer biomarkers by Duolink
Accelrys Announces Pfizer Inc. as the First Member of the Enterprise Cheminformatics Consortium - Consortium to Drive the Evolution of Enterprise Cheminformatics Systems Using Open and Flexible Service-Oriented Architecture
Roche Diagnostics Supports European Union’s DETECTIVE Project to Reduce Animal Testing
Gerhard Schratt, PhD and Professor Albert Sickmann receive the Analytica Research Prize
Merger of Exeter Analytical and Warwick Analytical Services creates a UK centre of excellence for Elemental Analysis